AIRLINK 204.00 Increased By ▲ 3.10 (1.54%)
BOP 10.05 Decreased By ▼ -0.10 (-0.99%)
CNERGY 6.92 Increased By ▲ 0.04 (0.58%)
FCCL 34.85 Increased By ▲ 0.76 (2.23%)
FFL 17.28 Increased By ▲ 0.30 (1.77%)
FLYNG 24.61 Increased By ▲ 0.57 (2.37%)
HUBC 137.49 Increased By ▲ 5.79 (4.4%)
HUMNL 13.84 Increased By ▲ 0.08 (0.58%)
KEL 4.90 Increased By ▲ 0.09 (1.87%)
KOSM 6.68 Decreased By ▼ -0.02 (-0.3%)
MLCF 44.20 Increased By ▲ 0.87 (2.01%)
OGDC 221.70 Increased By ▲ 2.95 (1.35%)
PACE 7.07 Increased By ▲ 0.09 (1.29%)
PAEL 43.00 Increased By ▲ 1.46 (3.51%)
PIAHCLA 17.12 Increased By ▲ 0.05 (0.29%)
PIBTL 8.60 Decreased By ▼ -0.05 (-0.58%)
POWER 8.99 Decreased By ▼ -0.12 (-1.32%)
PPL 190.00 Increased By ▲ 2.88 (1.54%)
PRL 43.00 Increased By ▲ 0.94 (2.23%)
PTC 25.00 Increased By ▲ 0.01 (0.04%)
SEARL 106.20 Increased By ▲ 5.90 (5.88%)
SILK 1.02 Increased By ▲ 0.01 (0.99%)
SSGC 42.75 Increased By ▲ 0.42 (0.99%)
SYM 18.35 Increased By ▲ 0.37 (2.06%)
TELE 9.17 Increased By ▲ 0.06 (0.66%)
TPLP 13.18 Increased By ▲ 0.25 (1.93%)
TRG 67.98 Decreased By ▼ -0.37 (-0.54%)
WAVESAPP 10.26 Decreased By ▼ -0.03 (-0.29%)
WTL 1.87 Increased By ▲ 0.01 (0.54%)
YOUW 4.15 Increased By ▲ 0.02 (0.48%)
BR100 12,137 Increased By 188.4 (1.58%)
BR30 37,146 Increased By 778.3 (2.14%)
KSE100 115,272 Increased By 1435.3 (1.26%)
KSE30 36,311 Increased By 549.3 (1.54%)

KARACHI: The Drug Regulatory Authority of Pakistan (DRAP) has registered’ another locally produced ventilator, ‘Innovent’, in Pakistan, sources said Tuesday.

As per details, the Innovent ventilator, manufactured by Essence Industries Karachi, has successfully completed its clinical trials.

DRAP has officially registered the Innovent ventilator and issued a license to Essence Industries for its local production. In addition to meeting domestic demand, the ventilators will also be exported, contributing to the Pakistan’s economy.

The Innovent ventilator has a shelf life of five years and is specifically designed for use by elderly patients, DRAP sources added.

Talking to a private television channel, DRAP CEO Dr. Asim Rauf said the priority of promoting Made in Pakistan medicines and medical equipment.

“Pakistan’s pharmaceutical industry has entered a new era, and the export of locally produced ventilators will generate significant foreign exchange for the country. These live-saving machines will also serve as a symbol of Pakistan’s global recognition,” Dr. Asim Rauf stated. He further highlighted that the success of Made in Pakistan medical devices reflects the country’s growing technological capabilities and commitment to innovation.

Earlier in 2021, the Drug Regulatory Authority of Pakistan (DRAP) registered an indigenously-developed intensive care unit (ICU) ventilator named “i-LIVE”.

The life-support machine was developed by the Pakistan Atomic Energy Commission (PAEC).

Chief Executive Officer of the DRAP Dr. Asim Rauf said that the i-LIVE ventilator was registered for a five-year period under the DRAP Act 2012 after its thorough technical examination.

Comments

Comments are closed.